Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemorrane Plus vs Hemorrane and Placebo for Uncomplicated Haemorrhoids
NCT05788497Phase 3Terminated
- Sponsor
- Faes Farma
- Start
- Mar 2023
- Primary completion
- Jan 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Hemorrane Plus in Hemorrhoids (3 arms), sponsored by Faes Farma. Primary endpoint: Percentage of responders at 7 days. Started Mar 2023; status: terminated.
02
Drugs
Hemorrane Plus
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT05788497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05788497.